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Cyclobutane thymidine dimer (T=T) is the major
DNA photoproduct formed in human skin after solar
radiation. We have developed a 32P-postlabeling
method suitable for quantitating T=T in human
urine with a detection limit of about 0.5 fmol per
10 ml urine. The method was used in the present
study to measure the daily T=T urinary level of two
volunteers over a 15 d period, including frequent sun
exposures ranging from 0 to 5 h daily. T=T was not
detected before or immediately (4 h) after the initial
sun exposure but was ®rst observed in urine samples
collected 18 h after the initial exposure. Thereafter,
urinary T=T levels gradually increased up to a peak
reached about 3 d after the maximum sun exposure.
The levels decreased during the following days but
were still detectable 8 d after the last sun exposure.
About 70±75% decrease in excreted T=T was
observed after 8 d. The T=T levels measured in
urine were lower but in the same order of magnitude
as the levels expected after a theoretical calculation
based on previous published results and reasonable
assumptions. This study shows the occurrence of
cyclobutane thymidine dimers in human urine after
skin exposure to solar radiation. Key words: 32P-post-
labeling/creatinine/cyclobutane thymidine dimers/high-
performance liquid chromatography/human urine/photo-
product/sun exposure/ultraviolet radiation. J Invest
Dermatol 117:263±268, 2001
S
olar radiation is harmful to human skin and it induces
sunburn, photoaging, and cancer. Ultraviolet (UV)
radiation represents only 5% of the intensity of the sun
emission energy reaching the earth's surface but it is the
main cause of skin damage. About 95% of UV radiation
reaching the earth's surface is UVA (315±400 nm) and 5% is UVB
(280±315 nm), whereas UVC (100±280 nm) is totally ®ltered by
the atmospheric ozone layer (IARC, 1992). Both UVA and UVB
have deleterious effects on human skin cells, but UVB is believed to
be the main contributor to erythema, i.e., skin reddening (Augustin
et al, 1997), and skin cancer (Black et al, 1997; English et al, 1997).
UVB induces speci®c DNA damages termed photoproducts:
cyclobutane dimers and 6-4 photoproducts between neighboring
pyrimidine bases on the same DNA strand (Bykov and Hemminki,
1995). In situ studies performed on human skin biopsies following
UVB or solar-simulated radiation helped to improve the general
understanding of the formation and repair of photoproduct in skin
DNA, and the in¯uence of parameters such as skin type, age,
gender, and use of sun screen (Bykov et al, 1998a, 1998b, 1999;
2000; Hemminki et al, 1999; Xu et al, 2000a, b); however, the
collection of skin biopsies is tedious because it is a clinical invasive
procedure.
Nucleotide excision repair is a DNA repair system in which
speci®c enzymes remove a 24±29 base DNA fragment containing a
lesion. After excision, further enzymatic processing breaks down
the oligomer to nucleotides, nucleosides and bases that are released
in the circulation and ®nally reutilized or excreted in urine (Diem,
1962; FoÈrsti et al, 1988). Several lesions of endogenous or dietary
origin have been detected in urine. Oxidative DNA damage such as
thymidine glycol and 8-hydroxy-deoxyguanosine have been
measured in urine using high performance liquid chromatography
(HPLC)/electrochemical detection and gas chromatography/mass
spectrometry (Simic, 1992). DNA alkylation products such as
3-methyl-adenosine and 3-ethyl-adenosine have been quantitated
in urine by gas chromatography/mass spectrometry or enzyme-
linked immunosorbent assay (Shuker et al, 1993). The analysis of
DNA lesions in urine generally involves prepuri®cation steps using
normal- or reversed-phase column, or immunoaf®nity columns.
The aim of this study was to develop a noninvasive method able
to quantitate (or re¯ect reliably) the formation and the removal of
photoproducts in human DNA, and demonstrate its usefulness. We
focused on human urine and looked for one of the major
photoproducts formed after solar-simulated radiation, i.e., cyclo-
butane thymidine dimer (T=T) (Bykov et al, 1998a, 1999).
Preliminary results have been published elsewhere (Hemminki
et al, 1999, 2001). Cyclobutane thymidine dimers have been
previously measured in the urine of psoriasis patients treated with
psoralen and UVA, using an enzyme-linked immunosorbent assay
antibody method (Ahmad et al, 1999; Cooke et al, 2001).
MATERIALS AND METHODS
Principle Cyclobutane thymidine dimer is not an appropriate substrate
for T4 polynucleotide kinase and, consequently, cannot be labeled
directly. As the parent dinucleotide (TpT) is easily labeled, we chose to
convert T=T to TpT by irradiation with UVC at 254 nm. The source
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of UVC irradiation was a Stratalinker UV Crosslinker 2400 with lamps
providing almost monochromatic 254 nm light. This lamp was used both
to prepare the reference T=T, and to revert T=T to TpT. The
reversion was carried out using a dose of 10 kJ per m2. The reversion
rate ranged from 30 to 50% and was determined in each experiment by
irradiating three standards (12, 36, and 108 fmol T=T dissolved in 40 ml
mQ water) and using the 32pTpT peak area obtained to draw a
calibration curve.
Sample collection Two volunteers (one man, 32 y old, 78 kg; one
woman, 30 y old, 60 kg) provided urine samples collected twice a day
(®rst morning urine, and evening urine) during 15 d. Each volunteer
provided one additional sample on day 23. Urine samples were
recovered in 2-ml Eppendorf tubes, labeled with the date and time of
collection, immediately frozen at ±20°C and kept frozen until analysis.
Sun exposure The sample collection took place at the end of
February±beginning of March. On day 0 of the study, the untanned
volunteers (skin types IV and V, according to IARC, 1992) traveled
from Sweden (cloudy winter weather with no signi®cant sun exposure)
to the Caribbean where they were exposed to solar radiation. The ®rst
sun exposure took place on day 1 in the afternoon. The sun exposures
mainly took place during periods spent at the beach. Approximately one
fourth of the time was spent under direct exposure during active periods
(swimming or sport), the remaining three-fourths being spent lying
partially protected by palm tree shadow. No prolonged sun bathing was
performed. Sunscreen (protecting factor 6, about 1 ml per cm2 applied,
Diffey, 1996) was applied on the legs, arms, and shoulders from days 1
to 9 for the male volunteer, and from days 1 to 15 for the female
volunteer. All sun exposures and their duration were recorded daily.
Knowing the height and weight of each volunteer, we could evaluate
the body surface at 2.1 m2 for the man, and 1.7 m2 for the woman
(Diem, 1962). We considered that half of the body surface was exposed
to sun when only arms and legs were uncovered (volunteers wearing
shorts and T-shirt).
During the 2 wk period, the weather was rather sunny but the sky
always displayed some scattered light clouds especially along the coastal
line (typical of the islands of the Caribbean archipelago). It is known that
even a complete light cloud cover does not stop more than 50% of UVB
energy ± compared with that from clear sky ± from reaching the earth's
surface (Diffey, 1991). The island of the study is situated at 16° of
latitude, so the typical value for ambient UVB radiation can be estimated
at about 6000 minimal erythema doses per year using the radiation level
of Hawaii, situated at 20° of latitude, as a comparison (Diffey, 1991).
Sample analysis Urine samples were allowed to melt at room
temperature, ®ltrated through 0.22 mm ®lters and 10 ml was injected on
the UV±HPLC system. In the system used, the retention time for T=T
was 16 min whereas the parent TpT had a retention time of 30 min, so
they did not coelute. The fraction eluting between 15.5 and 17 min was
collected, freeze-dried, and dissolved in 40 ml mQ water. The mixture
was then submitted to UVC irradiation (10 kJ per m2) for reversion of
T=T to TpT. TpT was labeled on the 5¢ side using the protocol
described previously (Bykov and Hemminki, 1995). The labeled samples
were diluted with water up to 12 ml and injected on the radioisotope
HPLC system.
Chromatographic systems UV-HPLC analyses were performed on a
Beckman instrument (model 126 pump) operated with System Gold and
coupled to a model 168 diode-array detector (Beckman Instruments, San
Ramon, CA). The urine samples were chromatographed on a 5 mm,
4.6 3 250 mm reversed phase C18 Luna column from Phenomenex
(Genetec, Kungsbacka, Sweden). A precolumn ®lter was positioned
before the column. The column was eluted isocratically for 5 min with
50 mM ammonium formate buffer (pH 4.6) and then with a gradient
from 0 to 30% methanol in 45 min at a ¯ow rate of 0.7 ml per min.
The labeled samples were analyzed on a Beckman instrument (model
126 pump) operated with System Gold and coupled to a model 171
radioisotope detector (Beckman Instruments). The urine samples were
chromatographed on a C18 Luna column (5 mm, 2 3 250 mm) from
Phenomenex, connected to a C18 Kromasil precolumn (5 mm,
2 3 50 mm) also from Phenomenex, and to a precolumn ®lter. The
column was eluted isocratically for 3 min with the buffer (500 mM
ammonium formate, 20 mM orthophosphoric acid, pH 4.6), and then
with a gradient from 0 to 20% methanol in 30 min. During all the
analysis, the Luna column was maintained at 40°C using a Cool Pocket
manufactured by Keystone Scienti®c (Belle fonte, PA). A switch system
was placed between the precolumn and the analytical column. During
the ®rst 2.5 min, the switch was on the waste position and the eluate
coming out of the precolumn, containing mainly unreacted 32P isotope,
was directed to the waste container. At 2.5 min, the switch was turned
to the column position to reconnect the precolumn to the analytical
column.
Data analysis For each urine sample the T=T level was adjusted with
the creatinine level, which re¯ects kidney glomerular ®ltration and is
nearly constant in the urine of a given individual. Creatinine levels were
determined by UV absorbance at 230 nm, i.e., area of the peak
corresponding to creatinine in UV±HPLC chromatograms. Fifteen of the
58 samples were analyzed in triplicate and the standard deviation was
usually lower than 10% of the mean (data not shown). Other samples
were analyzed once.
Amount of T=T ``expected'' in urine The amount of cyclobutane
thymidine dimer that can theoretically be expected in urine was
previously evaluated to 15 fmol per ml urine (Hemminki et al, 2001).
The theoretical calculation was based on the following assumptions: (i) a
dose of 400 J per m2 of solar simulating radiation (1±2 minimal
erythemal dose, about 15±30 min sun in Stockholm area in summer)
induces the formation of six TT=T/106 nucleotides in skin DNA, giving
a total amount of dimer (AT=T, GT=T, CT=T, and TT=T) at 24
T=T/106 nucleotides; (ii) the amount of DNA extracted from a 4 mm
diameter skin biopsy is about 10 mg, thus the amounts expected in 1 m2
of skin are 800 mg of DNA and 60 nmol of T=T; (iii) 25% of T=T is
removed from skin DNA in the ®rst 24 h after UV radiation (Xu et al,
2000b); (iv) all T=T removed from skin DNA ends up in the urine (1
litre per 24 h). The possible skin desquamation resulting from frequent
exposure was not taken into account in this calculation. This parameter
probably contributes to a loss of T=T.
RESULTS
Hypothesis testing Our search for photoproducts in urine
postulates that T=T released by DNA repair are not degraded
further and are excreted in urine as a dimer. The assumption was
tested by incubating at 37°C cyclobutane thymidine dimers with S9
mixture, which contains enzymes from rat liver homogenate along
with appropriate buffers and cofactors. After 24 h, the reaction
mixture still contained unchanged amounts of unmodi®ed
cyclobutane thymidine dimers suggesting that the hypothesis was
correct.
Radioisotope chromatogram A typical radioisotope
chromatogram obtained for a urine sample after sun exposure
containing a small amount (about 3 fmol) of T=T is presented on
Fig 1. The peak appearing at 27 min was identi®ed as 32pTpT, i.e.,
32P-labeled TpT, on the basis of three parameters: (i) it displayed
the same retention time as the standard 32pTpT; (ii) a
cochromatography experiment showed that it coeluted with the
standard 32pTpT; (iii) it demonstrated the same photochemical
Figure 1. Radioisotope HPLC chromatogram of human urine
containing a small amount (» 3 fmol) of T=T photoproduct. The
arrow shows the elution of the labeled TpT, the conversion product of
T=T.
264 LE CURIEUX AND HEMMINKI THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
reactivity as the standard 32pTpT, i.e., UVC irradiation of 32pTpT
produced labeled T=T and 6-4 photoproducts. Moreover, we
con®rmed that the 32pTpT peak was really representing UVC-
reversed T=T and not TpT contamination. We spiked aliquots of
T=T-free urine with known amounts of T=T. The radioisotope
chromatogram showed no peak at 27 min for the control sample
(T=T-free urine alone), the spiked samples showed a peak at
27 min, which was proportional to the amount of T=T added.
Urinary T=T levels The results on daily urinary dimer levels are
presented in Tables I and II. A few values are missing in Table I
and II due to the lack of samples. Before any signi®cant sun
exposure, the urine samples of both volunteers contained no T=T
(the detection limit of our method is about 0.5 fmol per 10 ml
urine). Cyclobutane thymidine dimer was not detected in the urine
samples collected on day 1 in the morning or in the evening (4 h
after the initial sun exposure). For both volunteers, T=T was ®rst
observed in the samples collected on day 2 in the morning, i.e.,
18 h after the initial exposure. T=T urinary level gradually
increased until a maximum on day 7 for the man and on day 11
for the woman. The highest individual T=T levels observed were
142 fmol per 10 ml urine for the man and 155 fmol per 10 ml urine
for the woman, which correspond to 635 fmol per mmol creatinine
and 934 fmol per mmol creatinine, respectively. For the man, T=T
levels generally decreased after day 7, although a lower maximum
appeared on day 12 and a shoulder was observed on day 14. For the
Table I. Urinary cyclobutane thymidine dimer (T=T) levels for male volunteer
Day Sun exposure (h3m2)
T=T levels
fmol per mmol creatinine
fmol per mmol creatinine
per m2 body surface mmol per dayaMorning Evening Mean
0 0 0 0 0 0 0
1 4.2 0 0 0 0 0
2 1.6 21 59 40 19 0.6
3 4.2 75 164 120 57 1.9
4 8.4 213 243 228 108 3.6
5 0 513 342 427 204 6.7
6 1.1 677 407 542 258 8.5
7 2.1 635 624 629 300 9.8
8 6.3 586 ND 586 279 9.1
9 3.2 ND 560 560 267 8.7
10 0 514 397 455 217 7.1
11 0 628 291 460 219 7.2
12 1.1 ND 524 524 249 8.2
13 0 393 339 366 174 5.7
14 3.2 447 344 396 188 6.2
15 1.1 389 158 274 130 4.3
¼
23 0 ND 64 64 30 1.0
aCalculation based on an average value of 200 mmol creatinine per kg per day for men. ND, not determined.
Table II. Urinary cyclobutane thymidine dimer (T=T) levels for female volunteer
Day Sun exposure (h3m2)
T=T levels
fmol per mmol creatinine
fmol per mmol
creatinine per m2 body surface mmol per dayaMorning Evening Mean
0 0 0 0 0 0 0
1 3.4 0 0 0 0 0
2 1.3 68 116 92 54 0.9
3 3.4 117 136 127 75 1.2
4 6.8 275 178 227 133 2.2
5 0 279 304 291 171 2.8
6 0.9 359 321 340 200 3.3
7 1.7 476 289 383 225 3.7
8 8.5 Nd ND ND ND ND
9 2.6 ND 399 399 235 3.8
10 0 613 344 479 282 4.6
11 0 934 738 836 492 8.0
12 0 ND 616 616 362 5.9
13 0 644 352 498 293 4.8
14 2.6 454 310 382 225 3.7
15 0.9 201 ND 201 118 1.9
¼
23 0 ND 62 62 36 0.6
aCalculation based on an average value of 160 mmol creatinine per kg per day for women. ND, not determined.
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woman, T=T amount steadily decreased after day 12. On day 23,
8 d after the last signi®cant sun exposure, urinary T=T amounts
remained at detectable levels (12 fmol per 10 ml urine for the man,
4 fmol per 10 ml urine for the woman).
Table III presents the cumulative sun exposure and the daily
urinary T=T level for the ®rst 4 d. A regression analysis of the
values shows a positive correlation between the cumulative sun
exposure and the excreted T=T concentrations, both for the man
and the woman. The data show a highly signi®cant relationship
between exposure and excreted levels during the ®rst days of
exposure.
In spite of the creatinine adjustment, the urinary T=T level in
the morning remained generally higher than that in the evening,
except for the ®rst 3±4 d. During the ®rst days, evening creatinine-
corrected T=T levels were higher or similar to morning levels. To
ease the comparison of the results between the man and the
woman, that have different body surfaces, the T=T urinary levels
were expressed in fmol per mmol creatinine per m2 of body surface.
These ®nal values are plotted on Figs 2 and 3.
DISCUSSION
This study is a sequential analysis on two individuals, and the results
obtained should not be generalized before a larger population is
studied.
The basic assumption of our work was that cyclobutane
thymidine dimer is excreted unchanged to urine. Our test with
microsomal enzymes suggested that no degradation took place. It
had been shown earlier that a dinucleotide cross-link by cis-
platinum is excreted to over 70% to urine when administered i.p. to
rats (FoÈrsti et al, 1988).
No urinary T=T before sun exposure The absence of
detectable T=T in urine collected before any signi®cant sun
exposure is obviously due to the absence or the very low level of
T=T in skin DNA. The fact that T=T was not detected in the
urine sample collected 4 h after the initial sun exposure but was
observed 18 h after sun exposure shows that there is a latency
period between the excision of T=T photoproducts from DNA
and the appearance of T=T in urine. Indeed, during nucleotide
excision repair, a 24±29 oligomer containing T=T is removed from
the DNA. The postexcision processing that releases T=T as a
monophosphate nucleotide dimer is certainly a partial reason for
the delay. Moreover, T=T must be transferred from the cell in the
epidermis to the lymphatic system and/or the blood before being
®ltrated through the kidney and ®nally released in the urine. The
transfer of T=T from one body compartment to another is
probably a slow step in the process because cell membranes are
expected to be poorly permeable to a charged molecule such as
T=T. No previously published suitable data was available to
compare with the less than 18 h delay between T=T formation in
DNA and its appearance in urine. Sontag et al (1995), however,
reported that in mouse, T=T-containing DNA in cells were
observed in lymph nodes as early as 1 h after 1.5 kJ per m2 UV
radiation exposure.
Increase in T=T urinary levels after sun exposure The
gradual increase in T=T observed in the urine of both volunteers
was related to the accumulation of photoproducts in skin DNA
during the ®rst days of exposure. The amount of T=T excised from
DNA was consequently increased and, after transport and ®ltration
delay, it was ultimately re¯ected as an increased level in urinary
cyclobutane thymidine dimer. Maximal levels were reached when
the rates of formation and removal were equally high. It was
reported that in skin cells from hairless mice, irradiated for 11
consecutive days with a daily dose of 1500 J per m2 UVB,
cyclobutane thymine dimers accumulated in epidermal cells and
reached a maximum level after 3 d. Thereafter, dimer levels
dropped to a lower, more constant level (Vink et al, 1993). In the
study of FoÈrsti et al (1988), rats were administered i.p. either cis-
platinum dinucleotide adduct or DNA containing cis-platinum
dinucleotide adduct. When the adduct was administered as such,
30% was recovered in urine after the 4 d, most of it (18%) being
recovered during the ®rst 24 h. When DNA containing the cis-
platinum adduct was administered, only about 1% was recovered
after 4 d, and the highest urinary amount was observed on the third
day following administration (FoÈrsti et al, 1988). The difference in
the time taken by cis-platinum adduct to reach the urine suggests
Table III. Trend analysis in the initial days: cumulative sun
exposure vs daily urinary T=T level
Day
Male Female
Cumulative
exposure
(h per m2)
Daily urinary
T=T (fmol per
mmol creatinine)
Cumulative
exposure
(h per m2)
Daily urinary
T=T (fmol per
mmol creatinine)
0 0 0 0 0
1 4.2 0 3.4 0
2 5.8 40a 4.7 92b
3 10 120a 8.1 127b
4 18.4 228a 14.9 227b
aRegression analysis: R2= 0.95; p < 0.01.
bRegression analysis: R2= 0.92; p < 0.01.
Figure 2. Relation between sun exposure and urinary T=T level
in male volunteer.
Figure 3. Relation between sun exposure and urinary T=T level
in female volunteer.
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that there is a major delay associated with the removal of
dinucleotide cross-link adduct from DNA and its release as a dimer.
Three day latency period In our study, there was a trend for a
3 d latency time between the maximum sun exposure and the
maximum T=T level in urine. The urinary T=T maximum did not
appear on the same day for the man and the woman (day 7 and day
11, respectively). This can be due to differences in the timetable of
exposure (the highest exposure was on day 4 for the man and on
day 8 for the woman) or differences in the rate of repair. The
second T=T maximum observed for the man on day 12 can be
associated with a prolonged sun exposure on day 8 followed by a
lower exposure on day 9. One interpretation of the small shoulder
appearing on day 14 for the man (but not for the woman) is that
urinary T=T levels accurately follows UV-induced T=T levels in
DNA. The shoulder seems indeed to re¯ect the 1 h sun exposure
received by the man (and not the woman) on day 12.
T=T urinary levels observed on days 5±7 (following a period
when both volunteers received the same number of hours of sun)
were higher for the man than for the woman. Assuming that T=T
urinary levels reliably re¯ect T=T DNA levels, this ®nding is not
consistent with the fact that the man has a darker skin type than the
woman (skin type V for the man and IV for the woman). The man
should, therefore, be prone to lower levels of photoproducts
formed in DNA than the woman, as melanin protects the genomic
DNA from UV radiation. Our result can be explained by
differences between the two volunteers in terms of: (i) repair
ef®ciency (the man's excision repair system might release more free
T=T than the woman's), or (ii) recovery of T=T in urine (the
proportion of free T=T recovered in urine might be higher for the
man than for the woman). Another explanation can also be a
difference in the use of sunscreen (body surface treated, amount
applied per cm2) between volunteers.
The urinary T=T levels measured on day 23 showed that 8 d
after the last exposure, the excretion level decreased by 77% for the
man, and 69% for the woman. This is consistent with the higher
urinary T=T levels observed for the man during the ®rst week of
the study.
Morning±evening difference in T=T urinary levels The
difference between morning and evening creatinine-adjusted T=T
levels tends to demonstrate that one or several of the processes
involved (i.e., T=T excision from DNA, transport from cells to the
lymphatic system or blood, kidney glomerular ®ltration rate) are
more ef®cient during the night compared with during the late
afternoon or early evening. An alternative explanation is that DNA
damage accumulated during the daytime and, considering the delay
in excretion, the levels were higher at night than during the
subsequent day. This circadian variation can also be explained by a
modi®cation the glomerular ®ltration rate of cyclobutane
thymidine dimer compared with that of creatinine, i.e., a relative
higher ®ltration rate of T=T during the night and the early
morning. Although a study on 10 healthy volunteers reported a
decreased excretion of creatinine during the night and morning
hours (Araki et al, 1983), we did not notice signi®cant differences
between morning and evening creatinine levels (data not shown).
As expected, considering the higher body and muscle weight for
the man, he displayed higher creatinine urinary levels than the
female volunteer (mean value of 0.163 and 0.123 mmol per 10 ml,
respectively, data not shown).
Measured and expected T=T urinary levels in the same
order of magnitude Taking into account all the urine samples
displaying detectable T=T levels, i.e., from day 2 of the study, the
average T=T level in urine can be roughly evaluated to 382 and
371 fmol per mmol creatinine for the man and woman,
respectively. Using the average creatinine level in urine cited
above, we evaluated the average urinary T=T level to be 6.2 and
4.6 fmol per ml urine for the man and the woman, respectively.
These values are in the same order of magnitude as the theoretically
expected level of 15 fmol per ml urine (Hemminki et al, 2001).
Skin type This study detected T=T in the urine of individuals
with rather dark skin (skin type IV and V). We can reasonably
expect similar or higher urinary T=T levels for persons with fair
skin (type I or II). For a given UV exposure, skin type II produces
more UV-induced DNA damages than skin type V (Hemminki
et al, 2001) and DNA repair rate does not differ signi®cantly
between different skin types (Xu et al, 2000b; Hemminki et al,
2001).
CONCLUSIONS
In summary, this study used a new sensitive 32P-postlabeling
method to demonstrate that cyclobutane thymidine dimers are
present in the urine of two volunteers following extensive exposure
to solar radiation. This study shows the occurrence of photo-
products in urine after skin exposure to solar radiation. The T=T
levels measured in urine are in the same order of magnitude as the
levels expected from a previous theoretical calculation. Future
studies are needed to measure the sensitivity of the 32P-postlabeling
method for quantitating urinary T=T following different levels of
controlled solar UV exposure. We also plan to investigate the
stability and the distribution of T=T in human body compartments
(blood plasma) and its recovery in urine.
The work was supported by the Swedish Cancer Fund and the Swedish Radiation
Protection 1nstitute.
REFERENCES
Ahmad J, Cooke MS, Hussieni A, et al: Urinary thymine dimers and 8-oxo-2¢-
deoxyguanosine in psoriasis. FEBS Lett 46:549±553, 1999
Araki S, Murata K, Yokoyama K, Yanagihara S, Niinuma Y, Yamamoto R, Ishihara
N: Circadian rhythms in the urinary excretion of metals and organic substances
in ``healthy'' men. Arch Environ Health 38:360±366, 1983
Augustin C, Collombel C, Damour O: Measurements of the protective effect of
topically applied sunscreens using in vitro three-dimensional dermal and skin
equivalents. Photochem Photobiol 66:853±859, 1997
Black HS, deGruijl FR, Forbes PD, et al: Photocarcinogenesis: an overview.
J Photochem Photobiol B 40:29±47, 1997
Bykov VJ, Hemminki K: UV-induced photoproducts in human skin explants
analysed by TLC and HPLC-radioactivity detection. Carcinogenesis
16:3015±3009, 1995
Bykov VJ, Janssen C, Hemminki K: High levels of dipyrimidine dimers are induced
in human skin by solar-simulating UV radiation. Cancer Epidemiol Biomarkers
Prev 7:199±202, 1998a
Bykov VJ, Marcusson JA, Hemminki K: Ultraviolet B-induced DNA damage in
human skin and its modulation by a sunscreen. Cancer Res 58:2961±2964,
1998b
Bykov VJ, Sheehan JM, Hemminki K, Young AR: In situ repair of cyclobutane
pyrimidine dimers and 6-4 photoproducts in human skin exposed to solar
simulating radiation. J Invest Dermatol 112:326±331, 1999
Bykov VJ, Marcusson JA, Hemminki K: Effect of constitutional pigmentation on
ultraviolet B-induced DNA damage in fair-skinned people. J Invest Dermatol
114:40±43, 2000
Cooke MS, Evans MD, Burd RM, Patel K, Barnard A, Lunec J, Hutchinson PE:
Induction and excretion of ultraviolet-induced 8-oxo-2¢-deoxyguanosine and
thymidine dimers in vivo: implications for psoralen and ultraviolet A. J Invest
Dermatol 116:281±285, 2001
Diffey BL: Solar ultraviolet radiation effects on biological systems. Phys Med Biol
36:299±328, 1991
Diffey BL: Sunscreens, suntans and skin cancer. People do not apply enough
sunscreen for protection. Br Med J 313:942, 1996
Diem K (ed): Documenta Geigy, Scienti®c Tables, 6th edn. Basle: Geigy JR, 1962, p 632
English D, Armstrong B, Kricker A, Fleming C: Sunlight and cancer. Cancer Causes
Control 8:271±283, 1997
FoÈrsti A, Takala M, Laatikainen R, Hemminki K: Excretion kinetics of the DNA
adducts of cis-diamminedichloroplatinum (II) formed in vitro in rat urine.
Carcinogenesis 9:1745±1748, 1988
Hemminki K, Bykov VJ, Marcusson JA: Re: Sunscreen use and duration of sun
exposure: a double-blind, randomized trial. J Natl Cancer Inst 91:2046±2047,
1999
Hemminki K, Xu G, Le Curieux F: Ultraviolet Radiation-Induced Photoproducts in
Human Skin DNA as Biomarkers of Damage and its Repair. IARC Science
Publication no. 154. Lyon: IARC, 2001, pp 69±79
IARC: Monographs on the Evaluation of Carcinogenic Risks to Humans Solar and Ultraviolet
Radiation. IARC Science Publication no. 55. Lyon: IARC, 1992, pp 43±72
Shuker DE, Prevost V, Friesen MD, Lin D, Ohshima H, Bartsch H: Urinary markers
for measuring exposure to endogenous and exogenous alkylating agents and
precursors. Environ Health Perspect 99:33±37, 1993
VOL. 117, NO. 2 AUGUST 2001 CYCLOBUTANE THYMIDINE DIMERS IN HUMAN URINE 267
Simic MG: Urinary biomarkers and the rate of DNA damage in carcinogenesis and
anticarcinogenesis. Mutat Res 267:277±290, 1992
Sontag Y, Guikers CL, Vink AA, et al: Cells with UV-speci®c DNA damage are
present in murine lymph nodes after in vivo UV irradiation. J Invest Dermatol
104:734±738, 1995
Vink AA, Berg RJ, de Gruijl FR, Lohman PH, Roza L, Baan RA: Detection of
thymine dimers in suprabasal and basal cells of chronically UV-B exposed
hairless mice. J Invest Dermatol 100:795±799, 1993
Xu G, Snellman E, Bykov V, Jansen C, Hemminki K: Cutaneous malignant
melanoma patients have normal repair kinetics of UV-induced DNA damage
in skin in situ. J Invest Dermatol 114:628±631, 2000a
Xu G, Snellman E, Bykov V, Jansen C, Hemminki K: Effect of age on the formation
and repair of UV photoproducts in human skin in situ. Mutat Res 459:195±202,
2000b
268 LE CURIEUX AND HEMMINKI THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
